Xiaolun Wang

2.0k total citations
23 papers, 449 citations indexed

About

Xiaolun Wang is a scholar working on Organic Chemistry, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Xiaolun Wang has authored 23 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 9 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Xiaolun Wang's work include Asymmetric Synthesis and Catalysis (6 papers), Melanoma and MAPK Pathways (5 papers) and Synthesis and Catalytic Reactions (4 papers). Xiaolun Wang is often cited by papers focused on Asymmetric Synthesis and Catalysis (6 papers), Melanoma and MAPK Pathways (5 papers) and Synthesis and Catalytic Reactions (4 papers). Xiaolun Wang collaborates with scholars based in United States, China and India. Xiaolun Wang's co-authors include James L. Leighton, Katsumi Kubota, Pui Yee Ng, Joseph Kim, Qinglin Meng, Dan M. Berger, Dennis Powell, Edward J. Salaski, Christopher L. Hamblett and Karen Collins and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Xiaolun Wang

22 papers receiving 444 citations

Peers

Xiaolun Wang

CTM

PFM

Yasunori Hase Japan

Andrej Boháč Slovakia

Jianghe Deng United States

Dmitry Borkin United States

Naoya Shindo Japan

Fabien Lecomte United Kingdom

Kevin P. Cusack United States

John J. Gaudino United States

Sarah J. Fink United States

William McCoull United Kingdom

Yasunori Hase Japan

Xiaolun Wang

286 ×0.9

125 ×0.8

66 ×0.9

30 ×0.8

CTM

7 ×0.3

PFM

Citations per year, relative to Xiaolun Wang Xiaolun Wang (= 1×) peers Yasunori Hase

Countries citing papers authored by Xiaolun Wang

Since Specialization

Citations

This map shows the geographic impact of Xiaolun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolun Wang more than expected).

Fields of papers citing papers by Xiaolun Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolun Wang. The network helps show where Xiaolun Wang may publish in the future.

Co-authorship network of co-authors of Xiaolun Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolun Wang. A scholar is included among the top collaborators of Xiaolun Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolun Wang. Xiaolun Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Christopher R., Ruth Aranda, James G. Christensen, et al.. (2022). Design and evaluation of achiral, non-atropisomeric 4-(aminomethyl)phthalazin-1(2H)-one derivatives as novel PRMT5/MTA inhibitors. Bioorganic & Medicinal Chemistry. 71. 116947–116947. 8 indexed citations

Wang, Xiaolun, et al.. (2021). Comparative efficacy of secukinumab against adalimumab and infliximab in patients with moderate-to-severe plaque psoriasis. Chinese Medical Journal. 135(1). 11–19. 8 indexed citations

Yashiro, Hiroaki, Kazunobu Aoyama, Tadahiro Nambu, et al.. (2020). Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis. PLoS ONE. 15(1). e0228212–e0228212. 26 indexed citations

Wang, Xiaolun & Joseph Kim. (2012). Conformation-Specific Effects of Raf Kinase Inhibitors. Journal of Medicinal Chemistry. 55(17). 7332–7341. 38 indexed citations

Hu, Yonghan, Derek C. Cole, R. Aldrin Denny, et al.. (2011). Discovery of indazoles as inhibitors of Tpl2 kinase. Bioorganic & Medicinal Chemistry Letters. 21(16). 4758–4761. 17 indexed citations

Wang, Xiaolun, Edward J. Salaski, Dan M. Berger, et al.. (2011). Structure-based design of isoindoline-1,3-diones and 2,3-dihydrophthalazine-1,4-diones as novel B-Raf inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(23). 6941–6944. 11 indexed citations

Wang, Xiaolun, Dan M. Berger, Edward J. Salaski, et al.. (2010). Indazolylpyrazolopyrimidine as Highly Potent B-Raf Inhibitors with in Vivo Activity. Journal of Medicinal Chemistry. 53(21). 7874–7878. 14 indexed citations

Wang, Xiaolun, Dan M. Berger, Edward J. Salaski, et al.. (2009). Discovery of highly potent and selective type I B-Raf kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(23). 6571–6574. 21 indexed citations

Wang, Xiaolun, Edward J. Salaski, Dan M. Berger, & Dennis Powell. (2009). Dramatic Effect of Solvent Hydrogen Bond Basicity on the Regiochemistry of S_NAr Reactions of Electron-Deficient Polyfluoroarenes. Organic Letters. 11(24). 5662–5664. 22 indexed citations

10.

Kubota, Katsumi, Christopher L. Hamblett, Xiaolun Wang, & James L. Leighton. (2007). Strained Silacycle Catalyzed Asymmetric Diels—Alder Cycloadditions: The First Highly Enantioselective Silicon Lewis Acid Catalyst (I).. ChemInform. 38(9). 1 indexed citations

11.

Kubota, Katsumi, Christopher L. Hamblett, Xiaolun Wang, & James L. Leighton. (2006). Strained silacycle-catalyzed asymmetric Diels–Alder cycloadditions: the first highly enantioselective silicon Lewis acid catalyst. Tetrahedron. 62(49). 11397–11401. 33 indexed citations

12.

Wang, Xiaolun, Qinglin Meng, Nicholas R. Perl, Yue Xu, & James L. Leighton. (2005). Tandem Aldol−Allylation and Aldol−Aldol Reactions with Ketone-Derived Enolsilanes: Highly Diastereoselective Single-Step Synthesis of Complex Tertiary Carbinols. Journal of the American Chemical Society. 127(37). 12806–12807. 21 indexed citations

13.

Ng, Pui Yee, et al.. (2002). Strained Silacycles in Organic Synthesis: A New Reagent for the Enantioselective Allylation of Aldehydes. Journal of the American Chemical Society. 124(27). 7920–7921. 142 indexed citations

14.

Wang, Xiaolun, et al.. (2002). Strained Silacycles in Organic Synthesis: The Tandem Aldol−Allylation Reaction. Journal of the American Chemical Society. 124(36). 10672–10673. 30 indexed citations

15.

Zhang, Rong, et al.. (2000). A new Procedure to 2-(2-Aryl-2-Aminoethenyl)-4,4-Dimethyl-2-Oxazolines Under Ultrasonically Dispersed Potassium—t-BuCl—i-Pr₂NH System. Synthetic Communications. 30(7). 1343–1350.

16.

Wang, Xiaolun, et al.. (2000). A new Procedure to Azoarene From Azoxyarene by Ultrasonic Dispersed Potassium. Synthetic Communications. 30(12). 2253–2257. 2 indexed citations

17.

Wang, Xiaolun, et al.. (1999). Syntheses Of Ketene Dithioacetal Derivatives Of 2,5-Piperazinedione. Synthetic Communications. 29(9). 1553–1560. 1 indexed citations

18.

Chen, Xu, et al.. (1999). A new procedure to enols of 2‐acylmethyl‐4, 4‐dimethyl‐2‐oxazolines under ultrasonically dispersed potassium system. Chinese Journal of Chemistry. 17(1). 80–83. 4 indexed citations

19.

Wang, Xiaolun, et al.. (1999). Reduction of Aromatic azo-, azoxy- and Nitrocompounds by Ultrasonically Activated Nickel. Synthetic Communications. 29(17). 3031–3037. 7 indexed citations

20.

Xu, Chen, et al.. (1999). N-Alkylation of 2-Methyl-2-Imidazolines by Phase Transfer Catalysis Without Solvent. Synthetic Communications. 29(17). 3025–3030. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact